TITLE: FDA (of the Philippines) Suspends Sale of Dengvaxia Dengue Vaccine
SENTENCE 1: It added that it “will immediately take appropriate measures to protect the public.”  The FDA urged the public and healthcare professionals to report to the FDA any incident “that reasonably indicates that Dengvaxia has caused or contributed to the death, serious illness, or serious injury to a consumer, a patient, or any person.”  Justice Secretary Vitaliano Aguirre II ordered the National Bureau of Investigation (NBI) on Monday to investigate the P3.5-billion dengue vaccination program of the DOH that put the lives of more than 733,000 public school children at risk.
SENTENCE 2: (CW)  By GMA News Online  The Food and Drug Administration of the Philippines ordered the suspension of the sale, distribution, and marketing of Dengvaxia vaccine and the withdrawal of the product in the market.
SENTENCE 3: The company said it will cooperate with the National Bureau of Investigation in its probe of the P3.5-billion dengue vaccination program of the DOH.

Bias label: highly
Annotator rationales:
Se si attribuiscono, anche ipoteticamente, gravi effetti collaterali ai vaccini, allora la popolazione può essere portata a non vaccinarsi